Mesalamine Tablet, Delayed Release
Product Images NDC 68382-435

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 68382-435). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mesalamine Delayed-release Tablets, Usp (D1574001 4164 4b13 B01a 568406c18f46 01)

This is not a valid molecular formula since it contains semicolons instead of subscripts. Therefore, it is not possible to generate a useful description.*

FDA Label Image

Mesalamine Delayed-release Tablets Usp, 800 mg (D1574001 4164 4b13 B01a 568406c18f46 02)

This text represents the label of a medication called Mesalamine which includes its NDC code (68382-435-28), its formulation (delayed-release tablets), its dosage strength (500mg), the number of tablets contained in the bottle (180), and the manufacturer (ZyDus Pharmaceuticals). The label also provides some instructions for use (i.e. take as directed), precautions (i.e. keep out of reach of children), and warnings (i.e. do not use if allergic to mesalamine).*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.